Diagnostic Histopathology
Volume 15, Issue 4 , Pages 203-212 , April 2009

Histopathology of inflammatory skin disease in oncological patients

References 

  1. Curth HO. Skin lesions and internal carcinoma. In:  Andrade R,  Gumport SL,  Popkin GL,  Rees TD editor. Cancer of the skin: biology-diagnosis-management. Philadelphia: WB Saunders; 1976;p. 1308–1341
  2. McLean DI. Cutaneous paraneoplastic syndromes. Arch Dermatol. 1986;122:765–767
  3. Brenner S, Tamir E, Maharshak N, Shapira J. Cutaneous manifestations of internal malignancies. Clin Dermatol. 2001;19:290–297
  4. Sabir S, James WD, Schuchter LM. Cutaneous manifestations of cancer. Curr Opin Oncol. 1999;11:139–144
  5. Rapini RP. Practical evaluation of skin lesions in immunosuppressed patients. Cutis. 1988;42:125–128
  6. Abeloff MD. Paraneoplastic syndromes: a window on the biology of cancer. N Engl J Med. 1987;317:1598–1600
  7. Cohen PR, Kurzrock R. Mucocutaneous paraneoplastic syndromes. Semin Oncol. 1994;24:334–359
  8. Kurzrock R, Cohen PR. Cutaneous paraneoplastic syndromes in solid tumors. Am J Med. 1995;99:662–671
  9. Hall TC. Paraneoplastic syndromes: mechanisms. Semin Oncol. 1997;24:269–276
  10. Moore RL, Devere TS. Epidermal manifestations of internal malignancy. Dermatol Clin. 2008;26:17–29
  11. Kleyn EC, Lai-Cheong JE, Bell HK. Cutaneous manifestations of internal malignancy: diagnosis and management. Am J Clin Dermatol. 2006;7:71–84
  12. Pipkin CA, Lio PA. Cutaneous manifestations of internal malignancies: an overview. Dermatol Clin. 2008;26:1–15
  13. Chung VQ, Moschella SL, Zembiwicz A, Liu V. Clinical and pathologic findings of paraneoplastic dermatoses. J Am Acad Dermatol. 2006;54:745–762
  14. Thomas I, Schwartz RA. Cutaneous paraneoplastic syndromes: uncommon presentations. Clin Dermatol. 2005;23:593–600
  15. Schwartz R. Acanthosis nigricans. J Am Acad Dermatol. 1994;31:1–19
  16. Stuart CA, Driscoll MS, Lundquist KF, Gilkison CR, Shaheb S, Smith MM. Acanthosis nigricans. J Basic Clin Physiol Pharmacol. 1998;9:407–418
  17. Schwartz RA, Williams ML. Acquired ichthyosis: a marker for internal disease. Am Fam Physician. 1984;29:181–184
  18. Rizos E, Milionis HJ, Pavlidis N, Elisaf MS. Acquired icthyosis: a paraneoplastic skin manifestation of Hodgkin’s disease. Lancet Oncol. 2003;3:727–735
  19. Farina MC, Tarin N, Grilli R. Acquired hypertrichosis lanuginosa: case report and review of the literature. J Surg Oncol. 1998;68:199–203
  20. Hegedus SI, Schorr WF. Acquired hypertrichosis lanuginosa and malignancy. A clinical review and histopathologic evaluation with special attention to the “mantle” hair of Pinkus. Arch Dermatol. 1972;106:84–88
  21. Requena L, Aguilar A, Renedo G. Tripe palms: a cutaneous marker of internal malignancy. J Dermatol. 1995;22:492–495
  22. Bazex A, Griffiths A. Acrokeratosis paraneoplastica — a new cutaneous marker of malignancy. Br J Dermatol. 1980;103:301–306
  23. Richard M, Giroux J. Acrokeratosis paraneoplastica (Bazex’ syndrome). J Am Acad Dermatol. 1987;16:178–183
  24. Bolognia JL, Brewer YP, Cooper DL. Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine. 1991;70:269–280
  25. Schwartz RA. Sign of Leser-Trelat. J Am Acad Dermatol. 1996;35:88–92
  26. Schwartz RA. Florid cutaneous papillomatosis. Clin Dermatol. 1993;11:89–91
  27. Kurzrock R, Cohen PR. Erythema gyratum repens. JAMA. 1995;273:594
  28. Boyd AS, Neldner KH, Menter A. Erythema gyratum repens: a paraneoplastic eruption. J Am Acad Dermatol. 1992;26:757–762
  29. Langolis JC, Shaw JM, Odland GF. Erythema gyratum repens unassociated with internal malignancy. J Am Acad Dermatol. 1985;12:911–913
  30. Wynick D, Hammond PJ, Bloom SR. The glucagonoma syndrome. Clin Dermatol. 1993;11:93–97
  31. Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. N Engl J Med. 1992;326:363–367
  32. Zantos D, Zhang Y, Felson D. The overall and temporal relationship association of cancer with polymyositis and dermatomyositis. J Rheumatol. 1994;21:1855–1859
  33. Anhalt GJ. Paraneoplastic pemphigus. Adv Dermatol. 1997;12:77–96
  34. Kimyai-Asadi A, Jih MH. Paraneoplastic pemphigus. Int J Dermatol. 2001;40:367–372
  35. Kossard S, Winkelmann RK. Necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol. 1980;3:257–270
  36. Bohn S, Buchner S, Itin P. Erythema nodosum: 112 cases: epidemiology, clinical aspects and histopathology. Schweiz Med Wochenschr. 1997;127:1168–1176
  37. Caughman W, Stern R, Haynes H. Neutrophilic dermatosis of myeloproliferative disorders. Atypical forms of pyoderma gangrenosum and Sweet’s syndrome associated with myeloproliferative disorders. J Am Acad Dermatol. 1983;9:751–758
  38. Fett DL, Gibson LE, Su WPD. Sweet’s syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc. 1995;70:234–240
  39. Andreev VC, Petkov I. Skin manifestations associated with tumors of the brain. Br J Dermatol. 1975;92:675–678
  40. Kurzrock R, Cohen PR. Erythromelalgia and myeloproliferative disorders. Arch Intern Med. 1989;149:105–109
  41. Wilkin JK. Flushing reactions: consequences and mechanisms. Ann Intern Med. 1981;95:468–476
  42. Rongioletti F, Cerroni L, Massone C, Basso M, Ciambellotti A, Rebora A. Different histologic patterns of granulomas in systemic lymphoma. J Am Acad Dermatol. 2004;51:600–605
  43. Pinzon R, Drewinko JM, Trujillo V. Pancreatic carcinoma and Trousseau’s syndrome: experience at a large cancer center. J Clin Oncol. 1986;4:509–514
  44. Grossman ME. Cutaneous manifestations of infections in immunocompromised host. Baltimore: Williams and Wilkins; 1995;62–7
  45. Brown AE. Overview of fungal infections in cancer patients. Semin Oncol. 1990;17:2–5
  46. Mays SR, Bogle MA, Bodey GP. Cutaneous fungal infections in the oncology patient. Am J Clin Dermatol. 2006;7:31–43
  47. Tan HH, Goh CL. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. Am J Clin Dermatol. 2006;7:13–29
  48. Infectious diseases of the skin. In:  Grayson W,  Calonje E,  McKee PH editor. Pathology of the skin with clinical correlations. vol. I.:St Louis: Elsevier Mosby; 2005;p. 837–992
  49. D’Antonio D, Pagano L, Gimernia C. Cutaneous asspergilosis in patients with hematological malignancies. Eur J Clin Microbiol Infect Dis. 2000;19:362–365
  50. Khardori N, Hayat S, Rolston K. Cutaneous rhisopus and aspergillus infections in five patients with cancer. Arch Dermatol. 1989;125:952–956
  51. Meyer RD. Cutaneous and mucosal manifestations of deep mycotic infections. Acta Derm Venerol. 1986;121:57–72
  52. Watts JC, Chandler FW. Fusariosis. In:  Connor DH,  Chandler FW,  Schwarts DA editor. Pathology of infectious diseases. vol. I.:Stamford: Appleton and Lange; 1997;p. 999–1001
  53. Adam RD, Hunter G, DiTomaso J. Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis. 1994;19:67–76
  54. Sugar AM. Mucormycosis. Clin Infect Dis. 1992;14:126–129
  55. Evenga F, Paricio JF, Merino FJ. Primary cutaneous cryptococcosis in a immunocompromised host: case review and report of the literature. Dermatology. 2002;204:145–149
  56. Pederson NB, Mardh PA, Halberg T. Cutaneous alternariosis. Br J Dermatol. 1976;94:201–209
  57. McSorley J, Shapiro L, Browenstein MH. Herpes simplex and varicella zoster: comparative histopathology of 77 cases. Int J Dermatol. 1974;13:69–75
  58. Drago F, Aragone MG, Lugani C. Cytomegalovirus in normal and immunocompromised individuals. A review. Dermatology. 2000;200:189–195
  59. Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol. 1991;18:1741–1743
  60. Chai C, White WL, Shea CR, Prieto VG. Epstein Barr virus-associated lymphoproliferative-disorders primarily involving the skin. J Cutan Pathol. 1999;26:242–247
  61. Greene SL, Su WPD, Muller SA. Ecthyma gangrenosum: report of clinical, histopathological and bacteriological aspects of eight cases. J Am Acad Dermatol. 1984;11:781–787
  62. Choi CM, Lerner EA. Leishmaniasis: recognition and management with a focus on immunocompromised patient. Am J Clin Dermatol. 2002;3:91–105
  63. Rueda RA, Valencia IC, Covelli C. Eosinophilic, polymorphic and pruritic eruption associated with radiotherapy. Arch Dermatol. 1999;135:804–810
  64. Requena L, Kutzner H, Mentzel T, Durán R, Rodríguez-Peralto HL. Benign vascular proliferations in irradiated skin. Am J Surg Pathol. 2002;26:328–337

PII: S1756-2317(09)00031-0

doi: 10.1016/j.mpdhp.2009.02.002

Diagnostic Histopathology
Volume 15, Issue 4 , Pages 203-212 , April 2009

Article Tools

* Image Usage & Resolution